Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy

Efficacy and Safety of Infliximab in HLA-B27-associated Ocular Inflammation Refractory or Intolerant to Conventional Immunomodulatory Therapy

Purpose: To determine the efficacy and safety of infliximab therapy in patients with HLA B-27-associated ocular inflammation resistant or intolerant to conventional immunomodulatory therapy. Methods: This was a retrospective observational case series. All cases were uveitic patients with posit...

Full description

Bibliographic Details
Main Authors: Asima Bajwa, Arash Maleki, Abhishek R Payal, Adriana Fandiño, María Inés Menéndez Padrón, Marisa Walsh, C Stephen Foster
Format: Article
Language:English
Published: Knowledge E 2020-10-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
hla-b27
immunomodulatory therapy
infliximab
tnf-α
uveitis
vasculitis
Online Access:https://doi.org/10.18502/jovr.v15i4.7786

Internet

https://doi.org/10.18502/jovr.v15i4.7786

Similar Items